Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...

Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer ...

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital PCR high complexity assays: Louisville, Colorado Friday, October 24, 2025, 12:00 ...

An update from IVD Medical Holding Limited ( ($HK:1931) ) is now available. IVD Medical Holding Limited has announced a proposed change of its ...

Immundiagnostik, Inc. has partnered with Epitope Diagnostics, Inc. (EDI) to offer the ECL100, a fully automated chemiluminescent immunoassay analyzer, and 50+ CLIA kits to laboratories across North ...

The investment enhances German facility to deliver more flexible and scalable drug delivery solutionsPIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global ...

An update from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) is now available. DiagnosTear Technologies Inc. announced an increase in its ...

Revvity, Inc. (NYSE: RVTY) today announced a program for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi (EURONEXT: SAN ...

Genetic Signatures (ASX: GSS) has reported a strong start to the new financial year with the commercial success of its ...

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.